SAN FRANCISCO, September 29, 2015 /PRNewswire/ --
The global transcriptomics technologies market is expected to reach USD 6.9 billion by 2022, according to a new report by Grand View Research Inc. The increasing demand for genetic identification and growing investment in R&D innovation along with the technological advancements across the product portfolio are the vital driving forces of this market. The increasing R&D investments are expected to highly influence biotechnological research and develop the commercialization over the forecast period. The rising investment is further anticipated to ensure positive growth and enhance business opportunities for pharmaceutical and biotechnological companies.
(Logo: http://photos.prnewswire.com/prnh/20150105/723757 )
Browse full research report with TOC on "Transcriptomics Technologies Market Analysis By Technology (Microarray, PCR, Gene Regulation, Next Generation Sequencing), By Application (Clinical Diagnostics, Drug Discovery & Research, Bioinformatics, Comparative Transcriptomics) And Segment Forecasts To 2022" at: http://www.grandviewresearch.com/industry-analysis/transcriptomics-technologies-market
Furthermore, the rising demand for efficient diagnostic methods drives the need for personalized medicines. Transcriptomics tools and the offered services identify potential drug targets, which are effective methods for diagnostic methodologies. The shifting preference of pharmaceutical companies towards therapeutics results in rising demand for the disease specific biomarker identification. This change ensures a potential opportunity in the commercialization of transcriptome research results. The escalating demand for efficient diagnostics and treatment measures in the areas of oncology, HIV, Alzheimer's disease, etc., also contributes significantly towards transcriptomics technologies market growth.
Further key findings from the report suggest:
Grand View Research has segmented the global transcriptomics technologies market on the basis of technology, applications, and region:
Browse related reports by Grand View Research:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Read Our Blogs - divog.org, terrapass.org, apavirginia.org
Media Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: http://www.grandviewresearch.com
Share this article